Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2007 16:21 ET | Source: Genesis Bioventures

Genesis Bioventures, Inc. Announces Filing of 8K for Investment From Firebird Global Master Fund II, Ltd.

SANTA MONICA, Calif., Feb. 8, 2007 (PRIME NEWSWIRE) -- Genesis Bioventures, Inc. (OTCBB:GBIW), a biomedical development corporation focusing on the development and commercialization of novel...
December 07, 2006 12:00 ET | Source: Genesis Bioventures

Genesis Bioventures Presents At the National Investment Banking Association's Capital Conference

LOS ANGELES, Dec. 7, 2006 (PRIME NEWSWIRE) -- Genesis Bioventures, Inc. (OTCBB:GBIW) today announced that its President and CEO, Mr. Douglas C. Lane, delivered four presentations on Genesis...
October 10, 2006 08:25 ET | Source: Genesis Bioventures

Genesis Bioventures Announces Agreement to Manufacture Mad Cow Disease Rapid Assay Test Kits

NEW YORK, Oct. 10, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) announced today that Prion Developmental Laboratories ("PDL"), its minority owned subsidiary company, entered into a...
October 05, 2006 10:30 ET | Source: Genesis Bioventures

Douglas Lane, President, CEO and Chairman of Genesis Bioventures Featured in Exclusive Interview With WallSt.net

LOS ANGELES, Oct. 5, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (OTCBB:GBIW), announced that Douglas Lane, GBIW's President, CEO, and Chairman, was featured in an exclusive interview with...
September 11, 2006 16:08 ET | Source: Genesis Bioventures

Genesis Bioventures to Present at the National Investment Banking Association's Capital Conference

NEW YORK, Sept. 11, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that its President and CEO, Mr. Douglas C. Lane, will present the newly restructured Genesis...
September 11, 2006 15:33 ET | Source: Genesis Bioventures

Genesis Bioventures Extends Prion Developmental Laboratories Acquisition Letter of Intent

NEW YORK, Sept. 11, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that the Company and Prion Developmental Laboratories ("PDL") mutually agreed on August 30, 2006 to...